Skip to content

To check Safety, Tolerability and effectiveness of HBWW-052005

An open label clinical study to evaluate the Safety, Tolerability and In-use efficacy of HBWW-052005

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049841
Enrollment
81
Registered
2023-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: HBWW-052005 - Baby Water Wipes: How to Use: Pull out 1 wipe & gently clean the baby. Frequency: Use as and when required Time period: 3 days - Group 1, 2 and 28 days - Group 3, 4. Con

Sponsors

Himalaya Wellness Company
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy subjects in the age group as below (inclusive of both genders) a.Group 1: >=18- b.Group 2: >= 2 - - c.Group 3: 0 months â?? - d.Group 4: Premature babies (babies born before 37 weeks) 2.Healthy day 1 babies not requiring medical attention. 3.Babies with signs of atopic dermatitis (dry skin, itchy skin, redness, sensitive skin, rashes) who does not require medical/systemic treatment to be included. Included in group 2 (6 subjects) and group 3 (15 subjects) with signs of atopic dermatitis. 4.Subjects in general good health as determined from a recent medical history. 5.Subjects mother/legal representative, preferably mother willing to give a voluntary written informed consent and agree to come for regular follow up. 6.Subjects mother/legal representative, preferably mother willing to abide by and comply with the study protocol. 7.Subjects should not participate in any other clinical study during participation in the current study.

Exclusion criteria

Exclusion criteria: 1.A known history or present condition of allergic response to any other concern that may require medical attention. 2.Chronic illness which may influence the cutaneous state. 3.Subjects not willing to stop the use of other baby powders during the study period. 4.Subjects participated in any other clinical study past 4 weeks 5.To determine the experience of test product on baby skin through subjective questionnaires on cleaning as pure as water, gentle cleansing without making skin dry for new-born skin, Suitable/ safe for newborn skin, suitable for sensitive skin babies, safe for use from day 1 of the baby, suitable/ safe for premature baby. keeps skin refreshed, keeps baby skin soft and smooth, mildness and gentleness tested in babies and safe on new-born 6.Local tolerance evaluation by the investigator. 7.Monitoring of AEs and SAEs

Design outcomes

Primary

MeasureTime frame
To evaluate the skin mildness, gentleness and irritability on skin by the investigator.Timepoint: 1. 2 - 12 years Day 01 and Day 03 2. 18 - 45 years: Day 01 and Day 03 3. 0 - 2 Years: Day1, Day 7, Day 28 4. Premature babies: Day1, Day 7, Day 28

Secondary

MeasureTime frame
To determine the experience of test product on baby skin through subjective questionnairesTimepoint: 2 - 12 years, 18 - 45 years: Day 03 0 - 2 Years, Premature babies: Day 7, Day 28;To evaluate the product safety of skin by local intolerance evaluation by investigatorTimepoint: 2 - 12 years, 18 - 45 years: Day 03 0 - 2 Years, Premature babies: Day 7, Day 28

Countries

India

Contacts

Public ContactMaheshvari Patel

NovoBliss Research Private Limited

dr.nayan@novobliss.in9909013286

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026